title: Potential clinical application of imatinib mesylate in patients with leukemic large granular lymphocytes.
authors.affiliation: Penn State Hershey Cancer Institute, College of Medicine, Penn State University, Hershey, Pennsylvania 17033, USA. jyang@psu.edu
authors.forename: Jun
authors.initials: J
authors.lastname: Yang
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Loughran
mesh_terms: D001549:Benzamides; D006086:Graft vs Host Disease / Q000139:chemically induced*; D006801:Humans; D000068877:Imatinib Mesylate; D054066:Leukemia, Large Granular Lymphocytic / Q000188:drug therapy*; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate